Show simple item record

dc.contributor.authorVassall, A
dc.contributor.authorSweeney, S
dc.contributor.authorBarasa, E
dc.contributor.authorPrinja, S
dc.contributor.authorKeogh-Brown, MR
dc.contributor.authorTarp Jensen, H
dc.contributor.authorSmith, R
dc.contributor.authorBaltussen, R
dc.contributor.authorM Eggo, R
dc.contributor.authorJit, M
dc.date.accessioned2021-02-12T09:53:43Z
dc.date.issued2020-11-19
dc.description.abstractCovid-19 requires policy makers to consider evidence on both population health and economic welfare. Over the last two decades, the field of health economics has developed a range of analytical approaches and contributed to the institutionalisation of processes to employ economic evidence in health policy. We present a discussion outlining how these approaches and processes need to be applied more widely to inform Covid-19 policy; highlighting where they may need to be adapted conceptually and methodologically, and providing examples of work to date. We focus on the evidential and policy needs of low- and middle-income countries; where there is an urgent need for evidence to navigate the policy trade-offs between health and economic well-being posed by the Covid-19 pandemic.en_GB
dc.description.sponsorshipWellcome Trusten_GB
dc.identifier.citationVol. 5, article 272en_GB
dc.identifier.doi10.12688/wellcomeopenres.16380.1
dc.identifier.grantnumber221303en_GB
dc.identifier.urihttp://hdl.handle.net/10871/124708
dc.language.isoenen_GB
dc.publisherF1000 Research / Wellcome Trusten_GB
dc.rights© 2020 Vassall A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.en_GB
dc.subjectCoviden_GB
dc.subjecthealth economicsen_GB
dc.subjectcost-effectivenessen_GB
dc.titleIntegrating economic and health evidence to inform Covid-19 policy in low- and middle- income countriesen_GB
dc.typeArticleen_GB
dc.date.available2021-02-12T09:53:43Z
dc.descriptionThis is the final version. Available on open access from F1000 Research via the DOI in this recorden_GB
dc.descriptionData availability: No data are associated with this article.en_GB
dc.identifier.eissn2398-502X
dc.identifier.journalWellcome Open Researchen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2020-11-19
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2021-02-12T09:50:26Z
refterms.versionFCDVoR
refterms.dateFOA2021-02-12T09:54:02Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2020 Vassall A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Except where otherwise noted, this item's licence is described as © 2020 Vassall A et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.